Claims for Patent: 5,013,743
✉ Email this page to a colleague
Summary for Patent: 5,013,743
Title: | Selective antibacterial agent against campytobacter |
Abstract: | The compound represented by the formula; ##STR1## [wherein R.sup.1 stands for hydrogen, methoxy or trifluoromethyl; R.sup.2 and R.sup.3, being the same or different from each other, stand for hydrogen or methyl; R.sup.4 stands for optionally substituted hydrocarbon residue; and n denotes 0 or 1] or a salt thereof show excellent antibacterial activities, against the genus Campylobacter, especially against Campylobacter pylori, and they are used for preventing or treating infectious diseases caused by the said bacteria. |
Inventor(s): | Iwahi; Tomoyuki (Suita, JP), Satoh; Hiroshi (Suita, JP) |
Assignee: | Takeda Chemical Industries, Ltd. (Osaka, JP) |
Application Number: | 07/478,405 |
Patent Claims: |
1. A method for combatting infectious diseases caused by the genus campylobater which comprises administering to a mammal in need thereof an antibiotially-effective amount of a
compound of the formula ##STR3## wherein R.sup.1 stands for hydrogen, methoxy or triflouromethyl; R.sup.2 and R.sup.3, being the same or different from each other, stand for hydrogen or methyl; and R.sup.4 stands for optionally substituted hydrocarbon
residue and n denotes 0 or 1, or a pharmacologically acceptable salt thereof.
2. A method according to claim 1, wherein R.sup.1 is hydrogen. 3. A method according to claim 1, wherein R.sup.3 is hydrogen. 4. A method according to claim 1, wherein R.sup.4 is fluorinated alkyl group. 5. A method according to claim 1, wherein R.sup.4 is fluorinated alkyl group. 6. A method according to claim 1, wherein R.sup.1 is fluorinated alkyl group. 7. A method according to claim 1, wherein the compound is 2-{3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2-yl}methylsulfinylbenzimidazol e. 8. A method according to claim l, wherein the compound is 2-{3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2-yl}methylthiobenzimidazole. 9. A method according to claim 1, wherein the compound is 2-{3-methyl-4-(2,2,3,3,3-pentafluoropropoxy)pyrid-2-yl}methylsulfinylbenzi midazole. 10. A method according to claim 1, wherein the compound is 2-{3-methyl-4-(2,2,3,3,3-pentafluoropropoxy)pyrid-2-yl}methylthiobenzimida zole. 11. A method according to claim 1, wherein the compound is 2-{3-methyl-4-(2,2,3,3-tetrafluoropropoxy)pyrid-2-yl}methylsulfinylbenzimi dazole. 12. A method according to claim 1, wherein the compound is 2-{3-methyl-4-(2,2,3,3-tetrafluoropropoxy)pyrid-2-yl}methylthiobenzimidazo le. 13. A method according to claim 1, wherein the compound is 2-{3-methyl-4-(2,2,3,3,4,4-hexafluorobutyloxy)pyrid-2-yl}methylsulfinylben zimidazole. 14. A method according to claim 1, wherein the compound is 2-{3-methyl-4-(2,2,3,3,4,4-hexafluorobutyloxy)pyrid-2-yl}methylthiobenzimi dazole. 15. A method according to claim 1, wherein the compound is 2-(3,5-dimethyl-4-methoxypyrid-2-yl)methylsulfinyl-5-methoxybenzimidazole. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.